CRON
Price
$2.41
Change
-$0.09 (-3.60%)
Updated
Oct 22 closing price
Capitalization
916.57M
13 days until earnings call
Intraday Buy/Sell Signals
OGI
Price
$1.69
Change
-$0.03 (-1.74%)
Updated
Oct 22 closing price
Capitalization
227.22M
Intraday Buy/Sell Signals
Interact to see
Advertisement

CRON vs OGI

Header iconCRON vs OGI Comparison
Open Charts CRON vs OGIBanner chart's image
Cronos Group
Price$2.41
Change-$0.09 (-3.60%)
Volume$1.12M
Capitalization916.57M
Organigram Global
Price$1.69
Change-$0.03 (-1.74%)
Volume$506.01K
Capitalization227.22M
CRON vs OGI Comparison Chart in %
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRON vs. OGI commentary
Oct 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a StrongBuy and OGI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 23, 2025
Stock price -- (CRON: $2.41 vs. OGI: $1.69)
Brand notoriety: CRON and OGI are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRON: 39% vs. OGI: 65%
Market capitalization -- CRON: $916.57M vs. OGI: $227.22M
CRON [@Pharmaceuticals: Generic] is valued at $916.57M. OGI’s [@Pharmaceuticals: Generic] market capitalization is $227.22M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.2B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 1 FA rating(s) are green whileOGI’s FA Score has 1 green FA rating(s).

  • CRON’s FA Score: 1 green, 4 red.
  • OGI’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRON and OGI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 3 TA indicator(s) are bullish while OGI’s TA Score has 4 bullish TA indicator(s).

  • CRON’s TA Score: 3 bullish, 7 bearish.
  • OGI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, OGI is a better buy in the short-term than CRON.

Price Growth

CRON (@Pharmaceuticals: Generic) experienced а -6.59% price change this week, while OGI (@Pharmaceuticals: Generic) price change was -13.78% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.96%. For the same industry, the average monthly price growth was -0.99%, and the average quarterly price growth was +41.89%.

Reported Earning Dates

CRON is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.96% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($917M) has a higher market cap than OGI($227M). OGI has higher P/E ratio than CRON: OGI (197.70) vs CRON (48.20). CRON YTD gains are higher at: 19.307 vs. OGI (4.969). OGI has higher annual earnings (EBITDA): -959K vs. CRON (-25.58M). CRON has more cash in the bank: 834M vs. OGI (36.8M). CRON has less debt than OGI: CRON (2.01M) vs OGI (9.15M). OGI has higher revenues than CRON: OGI (224M) vs CRON (130M).
CRONOGICRON / OGI
Capitalization917M227M404%
EBITDA-25.58M-959K2,668%
Gain YTD19.3074.969389%
P/E Ratio48.20197.7024%
Revenue130M224M58%
Total Cash834M36.8M2,266%
Total Debt2.01M9.15M22%
FUNDAMENTALS RATINGS
CRON vs OGI: Fundamental Ratings
CRON
OGI
OUTLOOK RATING
1..100
1978
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9189
PRICE GROWTH RATING
1..100
4648
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (67) in the Pharmaceuticals Other industry is in the same range as OGI (86) in the null industry. This means that CRON’s stock grew similarly to OGI’s over the last 12 months.

CRON's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as OGI (100) in the null industry. This means that CRON’s stock grew similarly to OGI’s over the last 12 months.

OGI's SMR Rating (89) in the null industry is in the same range as CRON (91) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to CRON’s over the last 12 months.

CRON's Price Growth Rating (46) in the Pharmaceuticals Other industry is in the same range as OGI (48) in the null industry. This means that CRON’s stock grew similarly to OGI’s over the last 12 months.

OGI's P/E Growth Rating (1) in the null industry is in the same range as CRON (6) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to CRON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRONOGI
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 24 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBRFX13.92N/A
N/A
Neuberger Berman Real Estate Tr
PQIZX14.02N/A
N/A
PIMCO Dividend and Income A
LVAMX11.49N/A
N/A
LSV US Managed Volatility Investor
MBVKX21.04N/A
N/A
BlackRock Large Cap Focus Value K
FKUQX26.54N/A
N/A
Franklin Utilities A

OGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been closely correlated with SNDL. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if OGI jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
-1.74%
SNDL - OGI
67%
Closely correlated
-2.22%
ACB - OGI
65%
Loosely correlated
-1.75%
TLRY - OGI
65%
Loosely correlated
-2.03%
CGC - OGI
62%
Loosely correlated
-3.65%
CRON - OGI
61%
Loosely correlated
-3.60%
More